Sep 07, 2017 14:21 pm UTC| Business
LOS ANGELES, Sept. 07, 2017 -- Chirp, the global leader in data-over-sound technology solutions, today announced that Marco Carvalho has joined the company as EVP and Chief Strategy Officer, effective immediately. ...
CGE Energy Completes Fabrication of 1/10th Scale Prototype WIND-e20 Wind Turbine
Sep 07, 2017 14:15 pm UTC| Business
BRIGHTON, Mich., Sept. 07, 2017 -- CGE Energy, Inc. (OTCPink:CGEI), the leading engineer of no capital cost energy solutions, announces the completion of a one-tenth scale working demonstration unit of its WIND-e20...
Data Deepens at Limeade with VP of Business Insights
Sep 07, 2017 14:15 pm UTC| Business
Bellevue, WA, Sept. 07, 2017 -- Limeade, an employee engagement company on a mission to improve well-being in the world, announced Tony Kippen as the new Vice President of Business Insights. Kippen will lead the data...
Ecomdash Helps Small Businesses Reach Their Full Potential
Sep 07, 2017 14:13 pm UTC| Business
CHARLOTTE, N.C., Sept. 07, 2017 -- Award-winning multi-channel ecommerce software, ecomdash, announced its latest offering today; a professional services package designed to meet the specific needs of small businesses....
Paxata Achieves Record Results in 1H 2017 with 160 Percent Growth in Year-over-Year Revenue
Sep 07, 2017 14:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 07, 2017 -- Paxata, the pioneer and leader in empowering all business consumers to intelligently transform raw data into ready information instantaneously, today announced that it closed the...
Sep 07, 2017 14:00 pm UTC| Business
PITTSBURGH, Sept. 07, 2017 -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive...
Akcea Therapeutics, Inc. (Nasdaq: AKCA) to Ring The Nasdaq Stock Market Closing Bell
Sep 07, 2017 14:00 pm UTC| Business
ADVISORY, Sept. 07, 2017 -- What: Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. focused on developing and commercializing drugs to treat patients with serious cardiometabolic...